News

AddToAny

Google+ Facebook Twitter Twitter

Nobel prize for british scientist

Sir Peter Ratcliffe has been jointly awarded the Nobel Prize in Physiology or Medicine for discoveries in how cells react to oxygen availability.

Alongside the other prize winners – William Kaelin Jr and Gregg Semenza – Sir Peter discovered how cells sense and adapt to changing oxygen availability and identified molecular machinery that regulates the activity of genes in response to varying levels of oxygen.

Their discoveries have also paved the way for new strategies to fight anaemia, cancer and other diseases.

Thirty-one years ago, Sir Peter qualified as a doctor from St Bartholomew’s Hospital Medical School, one of Queen Mary University of London’s founding institutions.

Professor Colin Bailey, Queen Mary’s Principal and President, said: “It is clear that this work is seminal, and it will have ramifications within and beyond physiology and medical science.”

The Nobel Committee announced: “The fundamental importance of oxygen has been understood for centuries, but how cells adapt to changes in levels of oxygen has long been unknown.

“Thanks to the ground-breaking work of these Nobel Laureates, we know much more about how different oxygen levels regulate fundamental physiological processes.”

Sir Peter said: “I am honoured and delighted at the news. I have had great support from so many people over the years.

“It’s a tribute to the lab, to those who helped me set it up and worked with me on the project over the years, to many others in the field, and not least to my family for their forbearance of all the ups and downs.”

The winners were awarded gold medals, diplomas and £740,000 to share.  

bit.ly/2Nslju8

Image credit | Shutterstock

Related Articles

CRISPR-Cas9 gene editing complex, illustration.Image credit - Science-Photo-Library-f0248864

Activating genes using CRISPR technology

There are over 7000 different rare genetic diseases, and often it can be a significant challenge and take a long time to receive a correct diagnosis.

Blue helix human DNA structure-Image credit-shutterstock-1669326868

The search for genes that cause diseases

A new statistical tool developed by researchers at the University of Chicago improves the ability to find genetic variants that cause disease.

pathogenspreadhr-CREDIT-spooky-pooka

Figuring out the threats: Problem-solving with genomics

As the COVID-19 enquiry continues to unpick the tangled threads of the pandemic response, little has been said about one of the most effective weapons against the SARS-Cov-2 virus – pathogen genomics.

breast cancer cells - CREDIT - Science Photo Library-c0559159

Breast cancer cells’ self-sacrifice is potential cause of relapse

For patients with early-stage breast cancer, there is a 7% to 11% chance of relapse within five years after receiving initial treatment.

Top